Anthony P. Finch
Mr Finch has served as a director since March 2003.
Mr Finch is the Chief Scientific Officer at the Irish National Blood Centre and National Tissue Typing Reference Laboratory and has been so for more than 10 years.
responsibilities included the direction, management, organisation, integration and restructuring of the national laboratories and their ancillary services to comply with the highest pharmaceutical standards.
has over 35 years of experience in cell separation and cryopreservation of cellular products with over 20 years of experience in cord blood processing.
In 1993 Mr Finch
pioneered the fractionation and isolation of cord blood stem cells for small volume cryogenic storage and has developed large scale processing in line with current Good Manufacturing Practice (cGMP).
has established several cord blood stem cell banks in the USA, Europe and Asia.
is currently seconded to both the Department of Health
and to the Health Service Executive playing a central role in the efficient management of the blood component supply-chain nationally and has implemented the European Directives for Blood and Tissue standards in hospitals nationwide.
works closely with the Regulatory Authority to ensure maintenance of these standards.
Among numerous professional affiliations, Mr Finch is a Fellow of both the Academy of Medical Laboratory Sciences and the Institute of Biomedical Sciences and is a member of the Cord Blood Stem Cell International Society.
The Board concluded that Mr. Finch’s extensive experience in cryopreservation of cellular products and his
resulting significant knowledge of our business, operations, services, and industry is valuable to the Board.
Mr. Finch’s experiences of over eight years on the Board, in addition to his
knowledge of cryopreservation of cellular products and related operational and strategic issues facing companies in our industry, enable him to impart valuable operational and strategic planning expertise to the Board, and his
insight is critical to board discussions.
OUR BOARD RECOMMENDS THAT STOCKHOLDERS VOTE “FOR” EACH OF MERCEDES WALTON, ANTHONY P. FINCH, SCOTT CHRISTIAN, ANDREW J. FILIPOWSKI, JAMES PELLOW AND ANTHONY ATALA, M.D. BY EXECUTING AND RETURNING THE ENCLOSED WHITE PROXY CARD OR VOTING BY ONE OF THE OTHER WAYS INDICATED THEREON.